Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Resmed Inc. buy UBS Group AG

Start price
€234.30
20.09.25 / 50%
Target price
-
20.09.26
Performance (%)
-0.73%
Price
€232.60
22.09.25
Summary
This prediction is currently active. Since the start of the prediction for Resmed Inc. the price has only changed by -0.73%. This prediction currently runs until 20.09.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this prediction
Performance without dividends (%)
Name 1w
Resmed Inc. -0.73%
iShares Core DAX® -0.560%
iShares Nasdaq 100 1.622%
iShares Nikkei 225® 1.807%
iShares S&P 500 0.859%

Comments by UBS_Group_AG for this prediction

In the thread Resmed Inc. diskutieren

ResMed (NYSE:RMD) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Ratings data for RMD provided by MarketBeat

Stopped prediction by UBS_Group_AG for Resmed Inc.

buy
Resmed Inc.

Start price
Target price
Perf. (%)
€241.30
01.08.25
€284.77
01.08.26
-3.61%
22.09.25

buy
Resmed Inc.

Start price
Target price
Perf. (%)
€207.50
24.04.25
€251.00
24.04.26
12.10%
22.09.25

buy
Resmed Inc.

Start price
Target price
Perf. (%)
€210.60
22.05.23
-
22.05.24
-3.75%
23.05.24